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When injected into speciﬁc rat brain regions, the neurotransmitter candidate L-proline produces various cardiovascular changes
throughionotropicexcitatoryaminoacidreceptors.Thepresentstudyusedanimmunohistochemicaldouble-labelingapproachto
determinewhetherintracisternallyinjectedL-prolineinfreelymovingrats,whichincreasesbloodpressure,activateshypothalamic
vasopressin-expressing neurons and ventral medullary tyrosine-hydroxylase- (TH-) containing neurons. Following injection of L-
proline,thenumberofactivated hypothalamicneuronsthat coexpressed vasopressinand c-Foswasmuch greater inthesupraoptic
nucleus (SON) than in the paraventricular nucleus (PVN) of rats with increased blood pressure. The number of activated
TH-containing neurons was signiﬁcantly greater following L-proline treatment than following control injections of artiﬁcial
cerebrospinal ﬂuid (ACSF). These results clearly demonstrate that intracisternally injected L-proline activates hypothalamic
supraoptic, but not paraventricular, vasopressin-expressing neurons and medullary TH-containing (A1/C1) neurons in freely
moving rats.
1.Introduction
The nonessential imino acid L-proline has been proposed
to be a neurotransmitter or neuromodulator of the central
nervoussystem[1–3].Itproducesvariousfunctionalchanges
in animals, such as cardiovascular changes in rats [4–8]
a n ds e d a t i o na sw e l la sh y p n o t i ce ﬀects under stressful
conditions in chicks [9, 10]. Intracisternal injections of L-
proline, but not D-proline, have been shown to cause an
increase in blood pressure in freely moving rats in a dose-
dependent manner via ionotropic excitatory amino acid
receptors in the brain [4, 5, 11]. This hypertensive response
to centrally administered L-proline can be almost inhibited
by intravenous preinjection of a vasopressin V1 receptor
antagonist alone and augmented in ganglionic blocking rats
where the augmented response was completely abolished by
the additional vasopressin receptor antagonist [11], suggest-
ing that the L-proline-induced pressor response could be
mainly mediated by the release of hypothalamic vasopressin
into the blood stream. Previous studies have shown that
intracisternally injected dye robustly stains the medullary
surface [12, 13]. These results suggest that intracisternally
injected L-proline might diﬀuse and reach the medullary
A1 catecholamine neurons, which send their terminals to
vasopressin-expressing neurons in both the paraventricular
nucleus (PVN) and the supraoptic nucleus (SON) of the
hypothalamus [14]. The goal of this study was to determine
theidentity ofthe L-proline-responsive cellsinfreelymoving
rats using double immunohistochemical detection of c-Fos
protein as a marker of neuronal activation and vasopressin
or the enzyme tyrosine hydroxylase (TH), a catecholamine
marker.
Brief reports of this work have appeared in abstract form
[15, 16].
2. Methods
All protocols and surgical procedures used in the current
study were performed in accordance with the Guiding2 Journal of Amino Acids
Principles for the Care and Use of Animals approved by the
Council of the Physiological Society of Japan, the guidelines
of the Committee of Animal Experimentation, Hiroshima
University, and the Committee on Research Facilities for
Laboratory Animal Science, Natural Science Center for
Basic Research and Development (N-BARD), Hiroshima
University.
2.1. Animal Care and Preparation. Eighteen male Wistar
rats (300–350g), which were cared for and handled by an
experimenter for at least three weeks prior to surgery, were
anesthetized with sodium pentobarbital (i.p., 50mg/kg).
Intracisternal polyethylene tubing was placed and ﬁxed on
the cranial bone with dental cement, as described previously
[11]. Seven days after the ﬁrst operation, the rat was
reanesthetized with sodium pentobarbital (i.p., 50mg/kg),
and a polyethylene catheter (sp 10 fused to sp 19, Natsume,
Japan) was placed in the terminal aorta to perform arterial
pressure measurements, heart rate measurements, and drug
administration. To reduce operation-induced stress, the
protocol excluded the venous catheter insertion step used in
previous studies [4, 5, 11] .C a g e sw e r ep l a c e di nar o o mw i t h
a controlled 12h light and 12h dark cycles. Water and food
p e l l e t sw e r es u p p l i e dad libitum.
2.2. Hemodynamic Measurements. The experiments with
freely moving rats began 2d after the ﬁnal operation. The
experiments were started in the morning between 8:00 and
10:00AM in their home cages. The rat was given a resting
period of at least 60min while its arterial blood pressure
and heart rate were monitored, as described previously
[11]. These parameters were recorded by a pen-writing
oscillograph following an injection of either intracisternal L-
proline (10µL of 1M L-proline) or artiﬁcial cerebrospinal
ﬂuid (ACSF; 15µL) for 90 min. Thereafter, Evans blue
dye solution (10µL, 0.2%) was injected to examine the
distribution of L-proline in the brain.
2.3. Brain Slice Preparation. Ten minutes after injecting the
dye, sodium pentobarbital (50mg/kg) was slowly infused
intra-arterially. The abdominal aorta of the rat was blocked
with a hemostat secured below the level of the thoracic
aorta, and the upper body was perfused intracardially with
isotonic saline containing heparin (10units/ml, 20–40mL),
followed by ﬁxative solution containing freshly prepared 4%
paraformaldehydebuﬀeredwithsodiumphosphate(200mL,
pH 7). After observing the dye distribution over the surface
of the whole brain, each brain block, including the hypotha-
lamus or medulla, was postﬁxed for 2h. Coronal slices that
were 50µm thick were made using a vibratome. Alternating
sections were used for each immunohistochemical staining
series. The sections were kept in sequential order using a
custom-made 24-well culture plate with a mesh ﬁber sheet
on the bottom.
2.4. Immunohistochemistry. Floating sections were pre-
treated with 0.3% H2O2 in phosphate buﬀered saline (PBS)
for 30min, followed by incubation in blocking solution
(3% bovine serum albumin and 0.3% triton X-100 in PBS,
pH 7) for 90min. The sections were incubated overnight
with a rabbit polyclonal anti-c-Fos antibody (1:10,000,
Calbiochem PC38, ex-Oncogene Ab-5) [17] diluted in
blocking solution containing sodium azide (0.2%). The
sections were incubated with a biotinylated goat anti-rabbit
IgG secondary antibody diluted in blocking solution for
2h, followed by incubation with horseradish peroxidase
avidin D reagent diluted in PBS for 1h. The staining was
detected as a black complex following the reaction with
3,3 -diaminobenzidine tetrahydrochloride (DAB, Dojindo
Laboratories, Japan) with 0.006% H2O2, 1% cobalt chloride,
and 1% nickel ammonium sulfate [17]. To perform double
staining, the sections were further incubated overnight
with either a rabbit polyclonal antibody against vasopressin
(1:17000, Chemicon AB 1565, which exhibited less than
1% cross-reactivity with oxytocin) or a rabbit polyclonal
antibody against TH (1:2500, Protos Biotech Corp, New
York, CA-101-bTHrab). In pilot experiments, each antibody
w a st e s t e dt oc o n ﬁ r mt h a ti tl a b e l e dc e l l sw i t hD A Bi n
the appropriate neuronal groups, including the vasopressin-
expressing neurons in the SON and PVN and TH-expressing
neurons in the medulla [18–20]. A similar reaction was used
for vasopressin or TH detection; however, only the DAB-
H2O2 solutionwasusedtoproduceadetectablebrownprod-
uct in the cytoplasm. Sections were washed thoroughly with
PBS between each reaction. Following antibody detection,
the sections were mounted on gelatinized glass slides, air-
dried overnight, dehydrated, cleared with xylene solutions,
mounted with Permount SP15 (Fisher Scientiﬁc), and sealed
with a coverslip.
2.5. Counting of Labeled Cells. The sections were examined
using a light microscope equipped with a mounted digital
camera, and images were captured using a DP70 Image
Analysis System (Olympus). The positively stained cells were
manually counted from printed, magniﬁed photographs.
The corresponding region was kept under the microscope
as a reference to adjust the focus on other vertical levels
in the section if necessary. The counts were made by a
researcher blinded to the treatment. When counting stained
cells in the hypothalamus, a print of a highly magniﬁed
photograph (100x) was used for selected slices that had the
densest staining at each nucleus level; these slices correspond
to the middle photographs shown in Figure 2. For analysis
of the frontal slices of the medulla, which have similar
structures throughout the levels, photographs were ﬁrst
taken in sequential order at low magniﬁcation (20x), and
then three slices −14.2mm (the caudal tip of the area
postrema), −13.6mm, and −12.6mm from Bregma were
determined using a brainstem atlas [20]. After numbering all
ofthelevelsoftheslicesinthephotographs,TH-positivecells
with c-Fos expression in the medulla were counted at higher
magniﬁcations in the corresponding slices. The numbers of
cells in two successive slices (doubled 50µm thickness =
100µm) were combined in every 0.2mm spaced in Figure 5.
The data shown in Figure 5 correspond to slices from more
than four rats.Journal of Amino Acids 3
The results are expressed as means ± SE. The data
were analyzed parametrically using grouped t-tests, repeated
measures one-way analyses of variance (ANOVAs) followed
by Dunnett’s test, or repeated measures two-way ANOVAs
followed by Scheﬀe’s test. Several groups of data were also
analyzed nonparametrically using the Wilcoxon rank sum
test, as indicated. P values < 0.05 were considered statistically
signiﬁcant.
3. Results andDiscussion
The current immunohistochemical investigation combined
with c-Fos detection as neuronal activation markers was
performed to identify possible neurons in the hypothalamus
and the medulla responding to L-proline injected into the
cisterna magna in the freely moving rat. Microinjections
of L-proline into the nucleus tractus solitarii [6] and the
caudal ventrolateral medulla [7, 8], which are nuclei related
to cardiovascular control, produced a depressor response
via ionotropic excitatory amino acid receptors in urethane-
anesthetizedrats.However,anesthetizedratsdidnotrespond
to intracisternally injected L-proline in pilot experiments.
Generalanesthesiamodiﬁesfunctionsofionchannelsmainly
for chloride and potassium to induce loss of consciousness
in animals [21]. It means a possible antagonized function
of anesthesia against original responses to L-proline in
the conscious animal. Therefore, the examination using
the immunohistochemical double-labeling method in the
conscious animal was ﬁt to examine responding neurons to
L-proline under the conscious state.
3.1. Cardiovascular Responses. The changes in mean arterial
blood pressure and heart rate of 10 L-proline-injected
rats and eight ACSF-injected control rats are shown in
Figure 1. Intracisternal injection of L-proline (1M, 10µL)
produced pressor and bradycardic responses, as observed in
previous studies [4, 11]. The previous study using sinoaortic
denervatedrats[11]alsosuggestedthatbradycardicresponse
isproducedbythebaroreceptorreﬂexasasecondaryeﬀectof
the pressor action of L-proline stimulation.
Some might think the hyperosmotic concentration of
L-proline injected into the cisterna magna (1M, 10µL)
but not L-proline itself could produce hyperosmotic eﬀect
on osmosensitive structures in the hypothalamus to release
vasopressin into the blood, resulting in the pressor response.
However, hypertonic mannitol injections (1M, 20µL) into
the same cisterna magna of the conscious rat produced no
change in blood pressure [22], and D-proline (1M, 10µL)
rather produced a depressor or no response [11]. It appears
to become osmoinsensitive concentration when the solution
reaches the osmo-sensitive structures along the ﬂow path,
possibly due to diﬀusion and constant ﬂow of cerebrospinal
ﬂuid. In addition, the pressor response was completely
blocked with kynurenate, the antagonist for ionotropic
excitatory amino acid receptors [5]. Therefore, L-proline
itself would be responsible for the pressor response, through
activationoftheL-proline-sensitiveionotropicreceptors,but
notoftheosmoticreceptorsforgeneralhypertonicsolutions.
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Figure 1: Changes in arterial blood pressure and heart rate
following intracisternal injection of L-proline or ACSF. The arterial
blood pressure increased, but the mean heart rate decreased, 5–
30minafteranintracisternalinjectionofL-prolineinfreelymoving
rats. One-way ANOVA showed a signiﬁcant diﬀerence (P<0.005)
intheheartrateoftheL-proline-treatedgroup,butnospeciﬁctimes
were detected by Dunnett’s test when control value was “before.”
Results are presented as means ± SE. ∗∗P< 0.01 and ∗P<0.05 by
one-way ANOVA followed by Dunnett’s test.
3.2. Double-Labeling of Hypothalamic Nuclei by Immunohis-
tochemistry. Brain sections of vasopressin-expressing neu-
rons in L-proline-injected and ACSF-injected rats are shown
inFigure 2.Activatedneuronsweremarkedbyblackmaterial
in their nuclei, which represents c-Fos protein expression
(Figure 2A (a)). Activation of a vasopressin-expressing neu-
ron was indicated by a black nucleus surrounded by a brown
stain, as shown in Figure 2A (b). A vasopressin-expressing
neuron that was not activated is shown in Figure 2A (c)
for comparison. In L-proline-injected rats, sections at every
level of the SON contained a high number of activated
vasopressin-expressing neurons, but sections of the PVN had
fewer activated vasopressin-expressing neurons (Figure 2A).
Sections from the ACSF-injected rats (negative controls)
showed a lower number of activated vasopressin-expressing
neurons than the L-proline-injected rats in both the SON
and the PVN (Figure 2B). In two pilot experiments using D-
proline (1M, 10µL), there were a few activated vasopressin-
expressing neurons in both the SON and PVN, similar to
the ACSF-injected rats. Vasopressin-expressing neurons were
selectively activated in the SON, but not in the PVN, in L-
proline-injected rats, as summarized in Figure 3 (left panel).4 Journal of Amino Acids
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Figure 2:Frontalsectionsshowingvasopressin-expressingneuronsinthehypothalamicSONandPVN.(A)IntracisternalL-proline-injected
rats. (B) Negative control, ACSF-injected rats. Representative higher magniﬁcation photographs are shown in (a), (b), and (c). The arrows
indicate the location of the magniﬁcation in the original photograph. f: fornix, 3V: third ventricle, OX: optic chiasm, opt: optic tract, LH:
lateral hypothalamic area.
To activate vasopressin neurons only in the SON with
intracisternally injected L-proline, direct stimulation of the
SON neurons would be possible. In the previous study,
the cardiovascular responses to intracisternally injected L-
proline were almost completely inhibited by a previous
injection of the broad type ionotropic excitatory amino
acid receptors antagonist [5]. If L-proline directly stim-
ulates the vasopressin neurons in the SON, it would be
through the ionotropic excitatory amino acid receptors.
Are there the possible receptors in vasopressin neurons of
the hypothalamus? Microinjection studies using the well-
established endogenous excitatory amino acid receptor ago-
nist L-glutamate combined with pharmacological methods
suggest mediation of the non-NMDA ionotropic excitatory
amino acid receptor but not of the NMDA receptor for
vasopressin release in the neurons of the SON [23]a sw e l l
as the PVN [24], monitoring blood pressure and heart rate
in conscious rats. In the current study, two rats showed back
ﬂow of dye into the third ventricle close to the PVN, as
mentioned later, but no signiﬁcant staining of vasopressin
neurons in the PVN. The reached concentration of L-proline
might be too low to produce any response in the PVN.
Microinjection experiments of L-proline itself into either
nucleus of the hypothalamus could be helpful to understand
the exact action of L-proline in the PVN as well as in the
SON.
3.3. Unspeciﬁed Cells with c-Fos Expression in the Hypo-
thalamus. In addition to vasopressin-expressing neurons,
unspeciﬁed cells expressing c-Fos were also detected after
L-proline stimulation, particularly in the PVN of the
hypothalamus (Figure 3, right panel). In the SON, 80% ofJournal of Amino Acids 5
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Figure 3: c-Fos-positive and vasopressin-positive neurons in the
SON and the PVN following L-proline or ACSF injection. There
were 10 L-proline-injected samples and eight negative control,
ACSF-injected samples. “Fos + VP” indicates the number of
vasopressin-expressing (VP) neurons with c-Fos stained nuclei.
“Fos” indicates the total number of neurons with c-Fos stained
nuclei. Data are presented as the means ± SE. ∗∗P<0.01 by t-test.
#P<0.05and ##P<0.01bytheWilcoxonranksumnon-parametric
test.
the c-Fos-positive cells were vasopressin-expressing neurons.
With respect to the large number of unspeciﬁed, activated
cells in the PVN, widely connected inputs expressing a
broad range of neurotransmitters have been described in the
brainstem and forebrain, including the hypothalamus [14].
The L-proline solution ﬂowing from the cisterna magna may
contact several loci, including A1 and A2 neurons in the
medullary surface and the arcuate nucleus in the hypotha-
lamus. There are numerous possible active sites and/or
pathways linking L-proline to the PVN, and the underlying
causes remain elusive. L-Proline appears to activate neurons
in the brain other than supraoptic vasopressin-expressing
neurons.
Based on the results of a preliminary study [15], unspec-
iﬁed c-Fos was predicted to be expressed in vasopressin-
containing neurons in both the SON and the PVN, because
both nuclei showed high levels of c-Fos expression that
coincided with changes in blood pressure. The prelimi-
nary results [15] were in agreement with pharmacologi-
cal evidence showing that an intravenous injection of a
vasopressin V1 receptor blocker eﬀectively inhibited the
hypertensive response to L-proline [11]. However, brain
regions containing vasopressin-expressing neurons also con-
tain neurons expressing a wide variety of neurotransmitters
[14]. Therefore, the current double-labeling analyses were
performed to determine whether intracisternal injection
of L-proline activated vasopressin-expressing neurons in
the hypothalamus to produce hypertension. Unexpectedly,
vasopressin-containing neurons were selectively activated
only in the SON, but unspeciﬁed neurons were activated in
the PVN, after intracisternal stimulation by L-proline.
3.4. Dye Distribution. The previous pharmacological exami-
nation suggested a major involvement of vasopressin release
intheL-proline-producedhypertension[11].Therecouldbe
direct contact of ﬂowed solution from the cisterna magna to
the vasopressin-containing neurons only in the SON located
on the bottom of the cranial bone. Therefore, possible
diﬀusedareaswereconﬁrmedespeciallyinthehypothalamus
after dye injection. Evans blue solution was distributed in the
SON on both sides of the optic chiasm at the base of the
brain in all rats included in the current study. Two of the
ten rats injected with L-proline exhibited backﬂow of the dye
solution into the third ventricle close to the PVN. Dye also
spread over the medullary surface and the caudal cerebellar
surface facing the cisterna magna, as described previously
[12, 13]. This dye distribution suggests a possible direct
activation of the neurons in the SON by L-proline ﬂowing
from the cisterna magna and another possible indirect
activation through the medullary noradrenergic A1 neuron.
3.5. Double-Labeling of Ventral Medullary Cells by
Immunohistochemistry. Medullary slices from both L-
proline-injected and control rats showed high numbers of
activated TH-expressing neurons, as shown in Figure 4.T H
is a marker enzyme for catecholamine-containing A1/C1
cells. Figure 5 summarizes the numbers of double-labeled
neurons in slices made across the ventral medulla every
0.2mm, expressing the summed number of cells with two
slices (100µm) in one distance level.
3.6. Data Analyses of Medullary TH-Containing Neurons.
The data on double-labeling cells of c-Fos and TH were
statistically analyzed. First, repeated measures two-way
ANOVAs were performed in two factors of drug treatments
and medullary distance levels. Thereafter, t-test was also
applied to drug treatments at each medullary distance level
based on a hypothesis.
There were signiﬁcant diﬀerences in the number of
double-labeled neurons between two treatments of L-proline
and ACSF (P<0.0003), as well as among slice levels (P<
0.0001) without interaction, according to repeated measures
two-way ANOVAs. Comparisons of each level with Scheﬀe’s
test supported signiﬁcant diﬀerence (P<0.0001) between L-
proline (mean ± SE, 19.2 ± 1.0, n = 114) and ACSF (13.5
± 1.1, n = 73) but detected no signiﬁcant diﬀerence among
slice levels. The analyses indicate that L-proline signiﬁcantly
activates TH-containing A1/C1 neurons across the medulla,
but with unspeciﬁed levels.
Because sensitivities to L-proline stimulation remain
unknown at each TH-expressing neuron, some TH-
expressing neurons might respond to L-proline and the
other might not respond. Therefore, t-test was applied to
each combination at diﬀerent distance levels, on the basis
of the hypothesis that each population at diﬀerent levels is
independent. Only one level at −14.6mm in Figure 5 (but
fourslices in the original counting number around this level)6 Journal of Amino Acids
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Figure 4: Double-labeled neurons showing black c-Fos nuclei and brown tyrosine hydroxylase-expressing (TH) neurons in medullary
sections from (a) L-proline-injected rats, and (b) negative control, ACSF-injected rats. Arrows indicate double-stained TH neurons, and
arrowheads alone indicate TH neurons without c-Fos expression, as shown in the magniﬁed photographs. The framed regions in the small
photographs (A1/C1 group) are shown magniﬁed to the right. AP: area postrema, cc: central canal, Gr: gracile nucleus, py: pyramidal tract,
Sol: nucleus solitary tract, sp5: spinal trigeminal tract, and Sp5: spinal trigeminal nucleus.
inthecaudalmedullawasdetectedwithsigniﬁcantdiﬀerence
(P<0.007). According to Buller et al. [18], the levels
between −15mm and −13.2mm from Bregma in Figure 5
are included only in the A1 group, and these levels contained
the slices of signiﬁcantly activated TH-containing neurons
following L-proline stimulation. Several speciﬁc caudal A1
neurons may be highly sensitive to L-proline stimulations.
With respect to the potential activation of the pathway
from A1 to the SON, the current immunohistochemical
data and analyses did not give convincing support, although
neurons across A1/C1 areas were signiﬁcantly activated by
L-proline stimulation. Additional investigations are required
for understanding of the network activation with L-proline
stimulation in details.
4. Conclusion
The current immunohistochemical double-labeling study
clearly demonstrated that intracisternal injection of the neu-
rotransmitter candidate L-proline produces preferentially
strong activation of vasopressin-expressing neurons only in
theSON,butnotinthePVN,infreelymovingrats.TheotherJournal of Amino Acids 7
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Figure 5: Numbers of c-Fos-positive and TH-positive neurons in
the medulla. Data are represented as the means + SE. Repeated
measures two-way ANOVAs indicated signiﬁcant diﬀerences (P<
0.0003) between two drug treatments as well as among distance
levels, and Scheﬀe’s test supported the signiﬁcant eﬀect of L-proline
but detected no signiﬁcant levels among distance levels. On the
basis of the hypothesis that the corresponding levels might have
distinctsensitivitiestoL-proline,t-testbetweenL-prolineandACSF
detected signiﬁcant diﬀerence at the slice level of −14.6mm (∗∗P<
0.01). A1 or C1 is located in the part of bar, according to Buller et
al. [18].
neurons including ventral medullary TH (A1/C1) neurons
and neurons other than vasopressin-expressing neurons in
the PVN were also activated by intracisternally injected L-
proline. The data could give a clue to ﬁnd acting sites of L-
proline in the brain of freely moving rats.
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